These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 26134017)

  • 1. [Clinical analysis of multiple myeloma patients with bone-related extramedullary disease: a longitudinal study on 834 consecutive patients in a single center of China].
    Deng S; Xu Y; An G; Sui W; Li Z; Zou D; Zhao Y; Qi J; Qiu L
    Zhonghua Xue Ye Xue Za Zhi; 2015 Jun; 36(6):501-6. PubMed ID: 26134017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of extramedullary disease on patients with newly diagnosed multiple myeloma].
    Tao Y; Jin SW; Wang Y; Tang SJ; Liu YF; Xu J; Pan MM; Zhang WP; Mi JQ
    Zhonghua Xue Ye Xue Za Zhi; 2023 Jan; 44(1):48-54. PubMed ID: 36987723
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical characteristics and survival outcomes of newly diagnosed multiple myeloma patients presenting with extramedullary disease: A retrospective study.
    Gao S; Li Q; Dong F; Yang P; Chen Y; Wang J; Wang Y; Jing H
    Leuk Res; 2022 Apr; 115():106793. PubMed ID: 35248783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Features of extramedullary disease of multiple myeloma: high frequency of p53 deletion and poor survival: a retrospective single-center study of 834 cases.
    Deng S; Xu Y; An G; Sui W; Zou D; Zhao Y; Qi J; Li F; Hao M; Qiu L
    Clin Lymphoma Myeloma Leuk; 2015 May; 15(5):286-91. PubMed ID: 25640025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and prognosis of multiple myeloma with bone-related extramedullary disease at diagnosis.
    Tian C; Wang L; Wu L; Zhu L; Xu W; Ye Z; Zhao Z; Wang Y; Zhang Y
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29685954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYC translocation is a valuable marker for the development and relapse of extramedullary disease in multiple myeloma.
    Song Y; Du J; Jin X; Li H; Jia C; Liu Y; Li K; Zhou D; Zhuang J
    Eur J Haematol; 2024 Dec; 113(6):824-832. PubMed ID: 39191670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1q21+ is associated with poor prognosis in newly diagnosed multiple myeloma patients with extramedullary disease: a retrospective study.
    Gao S; Dong F; Yang P; Chen Y; Wang Y; Wang J; Shi Y; Jing H
    Ann Hematol; 2024 Jun; 103(6):1979-1987. PubMed ID: 38206369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid extramedullary disease in multiple myeloma strongly predicts a poor prognosis and is associated with bortezomib resistance gene upregulation.
    Ji J; Guo R; Ma J; Cui Y; Li Y; Sun Z; Li J; Fan L; Qu X
    Clin Chim Acta; 2023 Aug; 548():117497. PubMed ID: 37479009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival trends and prognostic factors of patients with newly diagnosed multiple myeloma accompanied with extramedullary disease.
    Wang J; Shen N; Shen X; Zhang R; Jin Y; Li J; Chen L
    Ann Med; 2023; 55(2):2281657. PubMed ID: 38086395
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical Analysis of 46 Cases of Multiple Myeloma with Extramedullary Disease].
    Chao Y; Fan L; Gao XY; Ma YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Feb; 29(1):115-121. PubMed ID: 33554807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Adults with Acute Lymphoblastic Leukemia After Autologous Hematopoietic Stem Cell Transplantation and the Significance of Pretransplantation Minimal Residual Disease: Analysis from a Single Center of China.
    Ding Z; Han MZ; Chen SL; Ma QL; Wei JL; Pang AM; Zhang XY; Liang C; Yao JF; Cao YG; Feng SZ; Jiang EL
    Chin Med J (Engl); 2015 Aug; 128(15):2065-71. PubMed ID: 26228220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone-Related Extramedullary Disease in Newly Diagnosed Myeloma Patients is an Independent Poor Prognostic Predictor.
    Wang Y; Liu A; Xu T; Yin J; Chen W
    Clin Med Insights Oncol; 2022; 16():11795549221109500. PubMed ID: 35875418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic factors in newly diagnosed multiple myeloma patients with 1q21 amplification/gain treated with bortezomib-based regimens followed by autologous hematopoietic stem cell transplantation].
    Huang WY; Zou DH; Liu W; An G; Xu Y; Sui WW; Deng SH; Li CW; Liu H; Li J; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2018 Jun; 39(6):496-500. PubMed ID: 30032568
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of positron emission tomography with 18F-fluorodeoxyglucose integrated with computed tomography in the evaluation of patients with multiple myeloma undergoing allogeneic stem cell transplantation.
    Patriarca F; Carobolante F; Zamagni E; Montefusco V; Bruno B; Englaro E; Nanni C; Geatti O; Isola M; Sperotto A; Buttignol S; Stocchi R; Corradini P; Cavo M; Fanin R
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1068-73. PubMed ID: 25754658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autologous hematopoietic stem cell transplantation treatment for T cell lymphoblastic lymphoma].
    Wang P; Li CX; Zhang Y; Chen J; Chen XC; Yang D; Zhou J; Zong XP; Yang Z; Wu M; Yang MZ; Song YQ; Zhu J; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2020 Mar; 41(3):198-203. PubMed ID: 32311888
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term follow-up of multiple myeloma after autologous hematopoietic stem cell transplantation: a single center results].
    Sui WW; Zou DH; An G; Yi SH; Deng SH; Huang WY; Wang TY; Li J; Liu H; Fu MW; Lyu R; Liu W; Xu Y; Li ZJ; Zhao YZ; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2017 Jun; 38(6):499-504. PubMed ID: 28655093
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytogenetic and survival analysis in 315 multiple myeloma patients; five with orbital and eight with extramedullary disease.
    Tucker SM; Zaihra T
    Orbit; 2023 Dec; 42(6):603-611. PubMed ID: 36697375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and clinical features of extramedullary multiple myeloma in patients who underwent stem cell transplantation.
    Weinstock M; Aljawai Y; Morgan EA; Laubach J; Gannon M; Roccaro AM; Varga C; Mitsiades CS; Paba-Prada C; Schlossman R; Munshi N; Anderson KC; Richardson PP; Weller E; Ghobrial IM
    Br J Haematol; 2015 Jun; 169(6):851-8. PubMed ID: 25833301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of patients at high risk of secondary extramedullary multiple myeloma development.
    Stork M; Sevcikova S; Minarik J; Krhovska P; Radocha J; Pospisilova L; Brozova L; Jarkovsky J; Spicka I; Straub J; Pavlicek P; Jungova A; Jelinek T; Sandecka V; Maisnar V; Hajek R; Pour L
    Br J Haematol; 2022 Feb; 196(4):954-962. PubMed ID: 34726261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic value of (18)F-FDG PET/CT in newly diagnosed multiple myeloma patients].
    Wang CY; Wu L; Sun CT; Wang X; Xia B; Zhang YZ
    Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(4):301-306. PubMed ID: 30669718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.